YFYan Fang

Yan Fang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Fang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Huanyu Zhou

    Department of Gynecology and Obstetrics Qilu Hospital of Shandong University Jinan Shandong China

    2 shared publications
  • Qihui Yin

    Department of Gynecology and Obstetrics Qilu Hospital of Shandong University Jinan Shandong China

    2 shared publications
  • Ting Liu

    Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, People’s Republic of China

    2 shared publications
  • Yuyan Ma

    Department of Gynecology and Obstetrics Qilu Hospital of Shandong University Jinan Shandong China

    2 shared publications
  • Anqi Lu

    School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China

    1 shared publication
  • Chan Gao

    The Medical Department, 3D Medicines Inc., Shanghai, China

    1 shared publication

Latest Publications

  • Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities

    by Xinmao Yang, Jie Wang, Xiaotao Jia, Yaqian Yang, Yan Fang, Xiaoping Ying, Hong Li, Meiqian Zhang, Jing Wei, Yanfang Pan

    Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β plaques, neurofibrillary tangles, and chronic neuroinflammation. Microglial cells, the resident immune cells in the central nervous system, play a crucial role in the pathogenesis of AD. Microglia can undergo polarization, shifting between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes in response to different stimuli. Dysregulation of microglial polarization towards the pro-inflammatory phenotype leads to the release of inflammatory cytokines, oxidative stress, and synaptic dysfunction. These processes contribute to neuronal damage and cognitive decline in AD. However, several challenges remain in this field. The complex molecular mechanisms governing microglial polarization in AD need to be further elucidated. In this review, we discuss the mechanisms underlying microglial polarization in AD and its implications in disease progression.


  • The role of p53‐MDM2 signaling in missed abortion and possible pathogenesis

    by Ting Liu, Min Yan, Fen Liu, Yuyan Ma, Yan Fang

    Background: Missed abortion is one of the common obstetrical and gynecological complications, angiogenesis is the most important factor in fetal and placental development. However, the definite etiology and pathogenesis are not fully understood.Methods: The mRNA levels of p53, MDM2, VEGF, and HIF‐lα were detected in 60 villous samples of missed abortion patients and 64 healthy controls by quantitative reverse‐transcription polymerase chain reaction (qRT‐PCR). Immunohistochemistry was used to explore the expression and correlation of p53, MDM2, VEGF, and HIF‐lα in villous tissues. Furthermore, we upregulated MDM2 expression in JEG‐3 and BeWo cells under hypoxia, combined with Nutlin3, the cell cycle was determined using flow cytometry and the expressions of p53, MDM2, VEGF, and HIF‐1α were determined by qRT‐PCR and western blot.Results: qRT‐PCR demonstrated that the expressions of p53, MDM2, and HIF‐1α were significantly increased and VEGF was decreased in missed abortion group compared with normal pregnancies. Correlation analysis found that p53 was positively correlated with MDM2 and HIF‐1α, and negatively correlated with VEGF in missed abortion group. After administration of Nutlin3, overexpression of MDM2 could arrest cell cycle in G1 phase and reduce the proportion of S phase. The expression of p53 and MDM2 of JEG‐3 cells and BeWo cells which transfected with pcDNA3.1‐MDM2 plasmid were markedly increased after Nutlin3 addition under hypoxic conditions, while the expression of VEGF and HIF‐1α decreased.Conclusion: Our data indicated that during the development of villi in early pregnancy, p53‐MDM2 signaling regulate cell cycle and angiogenesis through interaction with HIF‐1α and VEGF, which may be a crucial factor affecting pregnancy outcomes.


  • Association of β‐arrestin1 and p53‐Mdm2 signaling in the development of missed abortion

    by Ting Liu, Yuyan Ma, Qihui Yin, Huanyu Zhou, Yan Fang

    Background: Missed abortion is a peculiar form of spontaneous abortion before 20 weeks' gestation. The definite etiology and pathogenesis are not fully understood. Recent studies have demonstrated that p53/Mdm2‐mediated ubiquitination of the IGF‐1R may be closely related to G‐protein‐coupled receptor kinases (GRK)/β‐arrestin1 system. Our previous studies have confirmed that the elevated expression of p53 and Mdm2 may be responsible for apoptosis during missed abortion. However, there was no information surrounding β‐arrestin1 in missed abortion.Methods: The mRNA levels of β‐arrestin1 in villous samples of 30 missed abortion patients and 31 healthy controls were determined by real‐time quantitative polymerase chain reaction (PCR). Immunohistochemistry was used to explore the expression and location of β‐arrestin1, p53, Mdm2, VEGF and HIF‐lα in trophoblasts. Transwell assays were performed to examine the influences of β‐arrestin1 expression on cell invasion. Furthermore, we tested the effect of β‐arrestin1 on the expression of p53, Mdm2, ERK, AKT and NF‐κB.Results: The expression of β‐arrestin1 in the villous samples of missed abortion group was dramatically lower than control group by quantitative real‐time‐PCR and immunohistochemistry. Furthermore, the patients with missed abortion showed significantly higher levels of p53, Mdm2, HIF‐lα and lower level of VEGF than healthy controls by immunohistochemistry. Functional studies showed that suppression of β‐arrestin1 in HTR‐8 cells inhibited cell invasion. The protein expressions of ERK and AKT in HTR‐8 cells were significantly downregulated by reducing the expression of β‐arrestin1, while the expressions of p53, Mdm2, NF‐κB were enhanced. Overexpression of β‐arrestin1 exhibited the adverse effect.Conclusion: Our data indicated that β‐arrestin1 play an important role in maintaining the maternal‐fetal tolerance, the decreased expression of β‐arrestin1 in the villous samples may be related with the development of missed abortion.


  • Open Access

    Association of β-arrestin1 and p53-MDM2 signaling in the development of missed abortion

    by Ting Liu, Yuyan Ma, Qihui Yin, Huanyu Zhou, Yan Fang

    Abstract BackgroundMissed abortion is a nonviable pregnancy before the 20th week of gestation with retained products of conception. The definite etiology and pathogenesis are not fully understood. β-arrestin1, the important dynamic multitask scaffold protein, it play an important regulatory role in interacting with G protein-coupled receptor (GPCR) to mediate its homologous desensitization and internalization. Recent studies have demonstrated that p53/Mdm2-mediated ubiquitination of the IGF-1R maybe closely related to G protein-coupled receptor kinases (GRK)/β-arrestin1 system. Our previous studies have confirmed that the elevated expression of p53 and Mdm2 may be responsible for apoptosis during missed abortion. However, there was no information surrounding β-arrestin1 in missed abortion.MethodsThe mRNA levels of β-arrestin1 in villous samples of 31 missed abortion patients and 31 healthy controls were determined by real-time quantitative PCR. Immunohistochemistry was used to explore the expression and location of β-arrestin1, p53, Mdm2, VEGF, HIF-lα in trophoblasts. We up-regulated and silenced the expression of β-arrestin1 by lentiviral transfection, transwell assays were performed to examine the influences of β-arrestin1 expression on cell invasion. Furthermore, we explored the expression of several important proteins which may be related to β-arrestin1.Resultsβ-arrestin1 mRNA levels in the villous samples from women with missed abortion were found to be dramatically lower than in women who had normal pregnancies. The immunohistochemistry results showed that β-arrestin1 positive staining was significantly lower in missed abortion group than that in normal pregnancies group. Furthermore, the patients with missed abortion showed significantly higher levels of p53, Mdm2 and HIF-lα, lower level of VEGF than healthy controls by immunohistochemistry. The protein expressions of p-ERK、p-AKT、p-p53 in HRT-8 cells were significantly downregulated by reducing β-arrestin1 expression, while the expression of p-NF-ΚB、p-Mdm2 were enhanced. Overexpression of β-arrestin1 exhibited the adverse effect. The loss expression of β-arrestin1 expression was significantly related with decreased cell invasion ability.ConclusionOur data indicated that β-arrestin1 could play an important role in maintaining the maternal-fetal tolerance, the decreased β-arrestin1 expression in the villous samples may be related to the development of missed abortion.

  • Open Access

    The diagnosis and treatment of adrenocortical carcinoma in pregnancy: a case report

    by Yuanli Zhang, Zeng Yuan, Chunping Qiu, Shuyi Li, Shiqian Zhang, Yan Fang

    Background: Pregnancy complicated with adrenocortical carcinoma (ACC) is a sporadic syndrome that is characterized by hypertension, uncontrolled hypokalemia, severe heart failure, premature delivery and other adverse effects. The clinical presentation of adrenocortical carcinoma is vague and nonspecific, it is challenging to identify complications of pregnancy with adrenocortical carcinoma. Here we present a case of adrenocortical carcinoma during pregnancy. We describe how to distinguish secondary hypertension from other conditions and the importance of timely detection and treatment of such patients. Case presentation: A 22-year-old woman 30 weeks pregnant was hospitalized with uncontrolled hypertension and hypokalemia. An ultrasound examination of the right adrenal gland revealed a large mass. She underwent transabdominal adrenalectomy, and histopathology from the sample removed revealed an adrenocortical carcinoma. Five days after surgery, the patient had a premature rupture of the fetal membranes and gave birth to a newborn girl via vaginal delivery at 32 weeks of gestation. The newborn was transferred to the neonatal pediatrics ward, and the woman started receiving chemotherapy. Conclusions: Pregnancy with adrenocortical carcinoma is a rare condition. This case alerts the obstetricians that analysis of hypertension, hypokalemia, the plasma level and circadian rhythm of plasma cortisol provides a strategy to diagnose adrenocortical carcinoma during pregnancy.


  • Circulating tumor DNA-based mutational landscape of advanced colorectal cancer.

    by Fang Yan, Wei Gao, Lifei Zhu, Wenzhuan Xie, Chan Gao, Jing Zhao, Mengli Huang, Shangli Cai, Yi Zhong

    E15034 Background: Alterations in oncogenic driver genes are extensively tested to guide anticancer treatment in colorectal cancer (CRC). As the repertoire of therapeutic targets continue to grow, we are interested to interrogate the possibility of resorting to circulating tumor DNA (ctDNA) where tissue samples are not readily available. Methods: Targeted next generation sequencing (NGS) was performed on ctDNA obtained from patients with advanced CRC using a 150-gene panel. Mutational profiles of ctDNA were compared with those detected in tissue samples from the 3D Medicine database as well as The Cancer Genome Atlas (TCGA) database. Genomic aberrations such as single nucleotide variations (SNVs), insertions/deletions, copy number variations, gene rearrangement and fusions were analyzed. Results: Notably, 244 of 256 samples (95.3%) were ctDNA-positive, as indicated by a maximum somatic allele frequency (MSAF) of > 0%. At least one reportable genomic alteration was detected in 96.5% of all cases, with an average of 8.12 mutations per case. The most frequently mutated genes were TP53 (47%), APC (42%), KRAS (32%) in ctDNA. A similar trend was also observed for SNVs, where TP53 (46.9% vs. 77.6% vs. 53.8%), APC (41.8% vs. 66.0% vs. 73.0%), and KRAS (30.5% vs. 48.4% vs. 43.5%) had the highest mutation frequencies across three data sets (ctDNA, tissues and the TCGA database). The SNV profiles of therapeutically relevant genes for CRC were also largely consistent between ctDNA and the tissue samples included in the 3D Medicine database: BRAF (7.0% vs. 8.7%), KRAS (30.5% vs. 48.4%), NRAS (2.7 vs. 3.1%), ERBB2 (5.1% vs. 5.2%), MLH1 (0.8% vs. 2.9%), MSH2 (2.7% vs. 3.1%), and MSH6 (3.1% vs. 3.7%). Patients harboring copy number gains had a significantly higher level of MSAF than those free of gene amplifications (p < 0.0001). Conclusions: Mutational landscape of ctDNA in general correlated with that detected in prior tissue samples as well as the TCGA database, supporting a role for ctDNA testing as a complementary approach to tissue testing in CRC.

  • Open Access

    Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting “Trojan Horse” Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance

    by Kai Shi, Jianxiu Xue, Yan Fang, Hongshu Bi, Shan Gao, Dongjuan Yang, Anqi Lu, Yuai Li, Yao Chen, Liyuan Ke

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis in a variety of tumor cells, but not most normal cells. Nevertheless, its therapeutic potential is limited due to the frequent occurrence of resistance in tumor cells, especially hepatocellular carcinoma cell lines. Therefore, we investigated the reversal effect of STAT3-decoy oligonucleotides (ODNs) on TRAIL resistance. Methods. Considering that the drawback of poor cellular permeability and rapid degradation in vivo limited ODNs' further clinical applications, we developed a biomimetic calcium phosphate-reconstituted low density lipoprotein nanovehicle (CaP@LDL) that would serve as a “Trojan horse” to carry STAT3-decoy ODNs into tumor cells and then regulate TRAIL-induced apoptosis. Results. In comparison with native ODNs, the reconstituted CaP@LDL packaged ODNs showed significantly increased serum stability, cellular transfection, in vitro synergistic cytotoxicity and apoptosis in hepatoma cells, while there was no cytotoxicity to normal cells. The improved TRAIL sensitization is attributed to blocking of STAT3 signaling and consequent expression of the downstream target antiapoptotic gene. Following systemic administration, CaP@LDL displayed LDL-mimicking pharmacokinetic behavior such as attenuated blood clearance as well as enhanced accumulation in tumor and hepatorenal sites. With the synergistic combination of decoyODN/CaP@LDL, TRAIL dramatically inhibited hepatic tumor growth in a xenograft model and induced significant tumor apoptosis in vivo. Conclusion. These results suggested that CaP@LDL-mediated STAT3-decoy ODN delivery might be a promising new strategy for reversing TRAIL resistance in hepatocellular carcinoma therapy.